SynergenX Legacy Holdings, LLC and its affiliated clinic entities commenced Chapter 11 casesDkt. 1 on July 2, 2026, in the Southern District of Texas, and the proceedings have been designated as a complex Chapter 11 matterDkt. 2 based on stated liabilities exceeding $10 million and more than fifty parties-in-interest. The Debtors operate a network of 64 health clinics across 10 states, offering hormone optimization, weight-loss, and wellness services under a corporate structure that includes Low T Centers, Inc., TomorrowMed, LLC, and numerous regional Group Health entities, with CEO Wayne Wilson leading the filings and Frank Wright of the Law Offices of Frank J. Wright, PLLC serving as counsel.
The first-day agenda centers on procedural consolidation and operational stabilization. The Debtors have moved to jointly administer the casesDkt. 3 under lead case No. 26-90644 while preserving separate estates, and have sought emergency relief to maintain their existing cash management systemDkt. 6 of 13 accounts, honor critical vendor obligationsDkt. 5 estimated at an aggregate of $146,726.99, and secure adequate assurance of utility paymentsDkt. 4 to avoid service interruption across the clinic footprint.
The cases sit at the outset of first-day relief, with a consolidated hearing on the joint administration, cash management, and critical vendor motions scheduled for July 7, 2026, at 2:00 p.m. CT. No DIP financing, cash collateral order, sale process, or plan has yet emerged in the docket, leaving the restructuring path still to take shape as initial operational motions are heard.
